Korean new drug ‘Noltec’ draws series of interests from foreign markets
The value of the 14th Korean drug, ‘Noltec(Ilyang Pharmcaeutical),’ is being stressed again as getting interests from foreign markets. It has shown a favorable trend as entering in the top 5 of the Korean PPI agent market this year.
The Ministry of Health and Welfare announced on the 4th Ilyang ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
